Scientific Programme

13 Wednesday
Pre-congress Courses to be held at Instituto de Higiene e Medicina Tropical:

10:00

Haematology

Pre-congress Course 1

José Cortez • Rui Barreira

Leukemic phase of mature B-cell neoplasms

• Normal lymphocyte development
• WHO 2008 classification of mature B-cell neoplasms
• Clinical case presentations

 

Quality Control

Pre-congress Course 2

Rui Pimentel

A Validation tool

• Plan a procedure for Statistical Internal Quality Control
• Practical applications
• Examples in Clinical Chemistry

14:00

Parasitology

Pre-congress Course 3

Luis Távora Tavira

Parasitic Diseases: from clinics to the bench and back

• Update in parasitological diagnostic techniques
• Virtual learning tools: The e-MEDICINimage continous learning programme in Parasitology
• Clinical Cases

 

Flow Cytometry

Pre-congress Course 4

Jorge Candeias • Martin Peres Andrés

Flow Cytometry in Haematology

• Flow Cytometry Bridge between Past and Future
• Flow Cytometry in Hematopathology
• Clinical Cases: Study by Flow Cytometry of Mature B Cells Neoplasms

Scientific programme sessions to be held at Lisbon Congress Centre:

17:00

AUD1

Opening Ceremony with Opening Lecture

Opening Ceremony

18:00

Welcome Reception

Welcome Reception
14 Thursday
 

08:30

AUD1

How to approach obesity from a laboratory point of view?

Plenary Lecture 1

Chair: Ilkka Mononen

• Tiago Guimarães

09:30

AUD1

How to get the best out of POC testing

Clinical Symposium 1

Chair: Sverre Sandberg • Co-Chair: Paulo Tavares

Population screening – Colorectal cancer meets Point of Care testing

Stephen Halloran

Guidelines, Accreditation, Training and Education: the GATEway to a Quality POCT service

• Ian Watson

A specially designed EQA program for analytical and postanalytical POC testin

Nina G. Christensen

 

AUD2

 

Learn (more) about E – learning

Educational 1

Chair: Ana Maria Simundic • Co-Chair: José Cortez

Quality of medical e-learning modules

Jürgen Stausberg

Medical e-learning – novel approach

Tomas Zima

EVICAB, A Novel Portal for Internet Education and Examination

Jaakko Malmivuo

e-HEMATimage

Joel Corberand

AUD3/4

Laboratory Medicine specialities training / education in Portugal (Patologia Clínica e Análises Clínicas)

Chair: Manuel Cyrne de Carvalho • Co-Chair: Franklim Marques

Educational Symposium 1

• To be announced

11:00

Coffee break | Exhibition

 

11:30

Poster presentations | Exhibition

Poster Presentation 1

 

13:00

Lunch | Exhibition

 

14:00

AUD1

Rational laboratory diagnosis

Educational 2

Chair: Mariam Klouche • Co-Chair: Manuel Cyrne de Carvalho

Why does it take too long time to evaluate if a test is good or not?

Andrea Rita Horvath

How to change physicians request patterns

• Sverre Sandberg

Economy and effectivenes of laboratory medicine: improvements through request management in hospitals

• Gregor Rothe

AUD2

What can the laboratory do for a child with recurrent infections

Clinical Symposium 2

Chair: Gerhard Zlabinger • Co-Chair: Margarida Guedes

Recurrent infections – lessons from primary immunodeficiency

• To be defined

Primary immunodeficiency: From clinic to diagnosis

Klaus Warnatz

Genetic etiologies of neutropenia

• Christoph Klein

15:30

Coffee break | Exhibition

16:00

AUD1

Who decides if there should be a screening program for prostate cancer and what tests to request?

Pros / Cons 1

Chair: Ilkka Mononen • Co-Chair: Reis Santos

Optimized cancer screening

Ulf Håkan Stenmark

Arguments against screening

Peter Bunting

AUD2

What to do when the antibiotics do not work? Is molecular identification of multiresistance (ESBL, MRSA, XDRTB) superior to culture?

Pros / Cons 2

Chair: Mariam Klouche • Co-Chair: Moniz Pereira

Molecular resistance testing is not required for routine diagnosis of tuberculosis

• Laura Brum

Molecular resistance testing is indispensable for routine diagnosis of tuberculosis

• Till Bachmann

To be announced

• To be announced

17:00

End of work sessions

15 Friday
 

08:30

AUD1

Progress toward a biomarker discovery-to-development pipeline in Clinical Proteomics

Plenary Lecture 2

Chair: Ilkka Mononen • Co-Chair: Francisco Amado

Steven A Carr

09:30

AUD1

What tests should be requested in a patient with suspicion of thrombosis / thrombofilia?

Clinical Symposium 3

Chair: Antonio Robalo Nunes • Co-Chair: Vana Kokkinou

Cancer is an acquired thrombophilia: causes and consequences

• Ismail Elalamy

HIT and thrombosis

• Theodore Theodoridis

An update of the laboratory diagnosis of thrombophilia. A special interest in thrombin generation

Hugo ten Cate

 

AUD2

 

European models for training in laboratory medicine

Educational 3

Chair: Lena Norlund • Co-Chair: Andrea Rita Horvath

Present Situation of Laboratory Medicine and Clinical Chemistry in Europe

• Wytze Oosterhuis

The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: harmonization of education in Europe

Simone Zerah

Education and training activities in EFCC

• Elizabeta Topic

Harmonization of Medical Training in Laboratory Medicine by UEMS

Utz Merten

AUD3/4

Laboratory Medicine for Family Medicine

Educational Symposium 2

• To be announced

11:00

Coffee break | Exhibition

 

11:30

Poster presentations | Exhibition

Poster Presentation 2

 

13:00

Lunch | Exhibition

 

14:00

AUD1

Clinical cases with voting

Educational 4

Chair: Patrick Twomey • Co-Chair: Henrique Reguengo

Carlos Vasconcelos

AUD2

How to evaluate cardiovascular risk

Clinical Symposium 4

Chair: Kari Pulkki • Co-Chair: To be announcedr

Apolipoproteins or lipid subfractions for clinical risk management? Pros and Cons

Michel Langlois

What can we learn from EQAs and audits for cardiac marker testing?

• Paul Collinson

How to evaluate cardovascular risk from a clinicians point of view

• Fausto Pinto

15:30

Coffee break | Exhibition

16:00

AUD1

Is there a role for laboratory medicine in the evaluation of a patient with dementia?

Pros / Cons 3

Chair: Elvar Theodorson • Co-Chair: Carolino Monteiro

CSF Biomarkers in Patients with Mild Cognitive Impairment

Niklas Mattsson

Current Status and Future of Biomarkers in the evaluation of patients with dementia

Leslie M. Shaw

AUD2

For which patients should you do pharmacogenetic testing before starting drug therapy

Pros / Cons 4

Chair: Ana-Maria Simundic • Co-Chair: Purificação Tavares

Use of Pharmacogenetics in Guiding Therapy with Coumarins

RHN van Schaik

Pharmacogenetic-Based Initial Dosing of Warfarin: Not Ready for Prime Time

• Charles S. Eby

17:00

End of work sessions

20:00

Closing Dinner

Closing Dinner
16 Saturday
 

08:30

AUD1

The political and strategic impact of emerging infectious diseases as major threats to health in Europe

Plenary Lecture 3

Chair: Mariam Klouche • Co-Chair: Luís Távora Tavira

• Zsuzsanna Jakab

09:30

AUD1

Can inflammatory tests predict survival?

Clinical Symposium 5

Chair: Gerhard Zlabinger • Co-Chair: To be announced

Inflammatory Biomarkers as Prognostic Indicators

• Eugene Braunwald

Prognostic ability of troponin and natriuretic peptides in cardiovascular disease

• Markus Noveanu

Does procalcitonin-guided antimicrobial therapy in the ICU improve survival?

Jens-Ulrik Jensen

 

AUD2

 

Clinical cases with voting

Educational 5

Chair: Patrick Twomey • Co-Chair:Henrique Reguengo

• Frey Ramos

11:00

Coffee break | Exhibition

 

13:00

AUD1

Closing Lecture

Closing Ceremony
13:30

Lunch | Exhibition